中文 | English
Return
Total: 4 , 1/1
Show Home Prev Next End page: GO
MeSH:(Atrial Fibrillation/*drug therapy/*genetics)

1.A Case Report of a Patient Carrying CYP2C9*3/4 Genotype with Extremely Low Warfarin Dose Requirement.

Soo Youn LEE ; Myung Hyun NAM ; June Soo KIM ; Jong Won KIM

Journal of Korean Medical Science 2007;22(3):557-559

2.Comparison of Aspirin and Naoxintong Capsule () with Adjusted-Dose Warfarin in Elderly Patients with High-Risk of Non-Valvular Atrial Fibrillation and Genetic Variants of Vitamin K Epoxide Reductase.

Huan WANG ; Xiao-Kai ZHOU ; Li-Fan ZHENG ; Xiao-Ying WU ; Hui CHEN

Chinese journal of integrative medicine 2018;24(4):247-253

3.Impact of six genetic polymorphisms on Warfarin maintenance dose variation in Chinese Han population.

Ying LOU ; Lulu HAN ; Yan LI ; Xiaoxing ZHANG ; Zhihong LIU ; Min TANG ; Haiwen YU ; Wei WANG ; Jianping XU ; Hong LIU ; Yishi LI

Chinese Journal of Medical Genetics 2014;31(3):367-371

4.Probucol attenuates atrial autonomic remodeling in a canine model of atrial fibrillation produced by prolonged atrial pacing.

Yong-tai GONG ; Wei-min LI ; Yue LI ; Shu-sen YANG ; Li SHENG ; Ning YANG ; Hong-bo SHAN ; Hong-jie XUE ; Wei LIU ; Bao-feng YANG ; De-li DONG ; Bao-xin LI

Chinese Medical Journal 2009;122(1):74-82

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4 , 1/1 Show Home Prev Next End page: GO